InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Metzger Michael A, Chairman & CEO. Insider active across 1 company, notably Syndax Pharmaceuticals Inc. Aggregated, 12 filings have been logged. History available since 13 September 2021. The latest transaction was disclosed on 16 December 2021 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations12 total
22,715 shares@ US$6.380.0072% mcap14.9% of flowCommon StockSEC:0001562180-21-007809
22,715 shares@ US$6.380.0072% mcap7.4% of flowCommon StockSEC:0001562180-21-007809:0
2,045 shares@ US$7.200.0007% mcap0.8% of flowCommon StockSEC:0001562180-21-007710:0
2,045 shares@ US$7.200.0007% mcap1.5% of flowCommon StockSEC:0001562180-21-007710
44,704 shares@ US$7.200.015% mcap16.0% of flowCommon StockSEC:0001562180-21-006652:0
44,704 shares@ US$7.200.015% mcap32.1% of flowCommon StockSEC:0001562180-21-006652
24,437 shares@ US$7.200.0084% mcap17.4% of flowCommon StockSEC:0001562180-21-006136
24,437 shares@ US$7.200.0084% mcap8.7% of flowCommon StockSEC:0001562180-21-006136:0
31,455 shares@ US$7.200.011% mcap11.2% of flowCommon StockSEC:0001562180-21-006060:0
31,455 shares@ US$7.200.011% mcap22.4% of flowCommon StockSEC:0001562180-21-006060
16,651 shares@ US$7.200.0057% mcap5.9% of flowCommon StockSEC:0001562180-21-005948:0
16,651 shares@ US$7.200.0057% mcap11.8% of flowCommon StockSEC:0001562180-21-005948
12 of 12 declarations
About Metzger Michael A
Michael A. Metzger serves as President and COO at Syndax Pharmaceuticals Inc. In this role, he is responsible for the overall strategy and operational direction of the company. With extensive experience in the pharmaceutical sector, he oversees daily operations and guides the company toward sustainable growth and increased profitability.
